Showing results (331-340 of 437) with videos related to
Sort By:
Pageof 44
Microbial Pathogenesis|February 5, 2020
Longitudinal study of BK Polyomavirus outcomes, risk factors, and kinetics in renal transplantation patientsBrandon Dow Chan, Gabriella Wong, Qing Jiang, et al.Nanoscale|March 26, 2011
Simultaneous synthesis and functionalization of water-soluble up-conversion nanoparticles for in-vitro cell and nude mouse imagingZhen-Ling Wang, Jianhua Hao, Helen L W Chan, et al.Nanoscale Advances|September 22, 2022
pH-responsive targeted gold nanoparticles for in vivo photoacoustic imaging of tumor microenvironmentsShiying Li, Kwok-Ho Lui, Tik-Hung Tsoi, et al.Radiology|February 24, 2010
Reduced bone perfusion in osteoporosis: likely causes in an ovariectomy rat modelJames F Griffith, Yi-Xiang J Wang, Hua Zhou, et al.International Journal of Biological Macromolecules|July 26, 2020
Polymannuronic acid prevents dopaminergic neuronal loss via brain-gut-microbiota axis in Parkinson's disease modelXiao-Li Dong, Xiong Wang, Fang Liu, et al.Chemistry (Weinheim an Der Bergstrasse, Germany)|September 4, 2013
Synthesis and characterization of luminescent cyclometalated platinum(II) complexes of 1,3-bis-hetero-azolylbenzenes with tunable color for applications in organic light-emitting devices through extension of π conjugation by variation of the heteroatomAlan Kwun-Wa Chan, Elizabeth Suk-Hang Lam, Anthony Yiu-Yan Tam, et al.Rheumatology (Oxford, England)|September 6, 2022
Lower risk of gout in sodium glucose cotransporter 2 (SGLT2) inhibitors versus dipeptidyl peptidase-4 (DPP4) inhibitors in type-2 diabetesJiandong Zhou, Xuejin Liu, Oscar Hou-In Chou, et al.Cardio-Oncology (London, England)|March 18, 2022
Adverse Cardiovascular Complications following prescription of programmed cell death 1 (PD-1) and programmed cell death ligand 1 (PD-L1) inhibitors: a propensity-score matched Cohort Study with competing risk analysisJiandong Zhou, Sharen Lee, Ishan Lakhani, et al.Journal of Alternative and Complementary Medicine (New York, N.Y.)|January 10, 2006
Ganoderma lucidum mycelium and spore extracts as natural adjuvants for immunotherapyWing Keung Chan, David Tai Wai Lam, Helen Ka Wai Law, et al.Metabolism: Clinical and Experimental|February 8, 2018
Fibroblast growth factor 21 in cardio-metabolic disorders: a systematic review and meta-analysisIshan Lakhani, Mengqi Gong, Wing Tak Wong, et al.Pageof 44